ADMdx

Turning images into insights

Menu
  • Home
  • About us
    • About ADMdx
    • Management team
    • Collaborations
  • Clinical trials
    • Capabilities
    • Subject inclusion
    • Enrichment and stratification
    • Detecting treatment effect
    • Data insight for planning & discovery
    • Our technology
  • Diagnostics
    • Overview
    • Dementia diagnostics
    • About dementias
    • About imaging
  • Publications
  • Contact
  • News

ADMdx awarded patent on determining information using the early timeframes of a PET scan

September 30, 2020 By ADMdx

September 30, 2020 – ADM Diagnostics has received a patent on a method that obtains information from a brain scan that would typically take much longer to measure. The first few minutes of a positron emission tomography (PET) scan contain information regarding brain blood flow and function.  Information regarding the amount of amyloid burden or other entities is not obtained until many minutes later.  To obtain both types of information requires scanning the patient for a long time or in two parts.  ADMdx’s method is able to obtain both types of information using the first 20 or less minutes. This has application in Alzheimer’s disease and in other brain disorders.

Filed Under: News

Copyright © 2021 ADM Diagnostics, Inc.